• About Us
  • Capabilities
    Capabilities

    Amanta Healthcare offers world-class sterile manufacturing backed by global quality standards and regulatory approvals.

    • Manufacturing Infrastructure
    • Quality Control Processes
    • Innovations
  • Products
    Therapeutic Range

    Explore Amanta’s comprehensive range of high-quality sterile products trusted by healthcare professionals worldwide.

    • Respiratory
    • Fluid Therapy
    • Diluents
    • Medical Consumables
    • Ophthalmics
    • Anti-Infectives
    • Injectables
    • OTC Range
  • Investors
  • Opportunities
    Opportunities

    Discover career growth and product partnering opportunities with Amanta - where innovation meets global impact.

    • Careers
    • Product Partnering
  • Sustainability
  • CSR
  • Contact
  • Home
  • Investors
  • Exchange Announcements

Exchange Announcements

Financial Year 2025-26

Q3
  • February 14, 2026

    Monitoring Agency Report Dec 2025

  • February 10, 2026

    Outcome of Board Meeting Held on 10.02.2026

  • February 2, 2026

    Board Meeting Intimation For the Quarter Ended December 31, 2025

  • January 20, 2026

    Shareholding Pattern Q3 – 2025-26

  • December 29, 2025

    Intimation of Closure of Trading Window December 31, 2025

Q2
  • November 14, 2025

    Monitoring Agency Report Sept 2025

  • November 12, 2025

    Intimation under Regulation 30

  • November 11, 2025

    Outcome of Board Meeting Held on 11.11.2025

  • November 3, 2025

    Board Meeting Intimation For the Quarter Ended 30th September 2025

  • October 17, 2025

    Shareholding Pattern Q2 – 2025-26

Advertisements

  • February 12, 2026

    Intimation - Newspaper Publication - Financial Results - 31st December, 2025

  • November 14, 2025

    Intimation - Newspaper Publication - Financial Results - 30th September, 2025

  • September 27, 2025

    Intimation - Newspaper Publication - Financial Results - 30th June, 2025

Material Events

  • February 16, 2026

    Intimation for upgrade in Credit rating

  • February 10, 2026

    Intimation for Change in Management

Important Information for Shareholders

  • February 2, 2026

    Intimation for Opening of Special Window for Transfer of Physical Shares

footer-logo
Its all about life!
Therapeutic Range
  • Respiratory
  • Ophthalmics
  • Fluid Therapy
  • Anti-Infectives
  • Diluents
  • Injectables
  • Medical Consumables
  • OTC Range
Other links
  • Home
  • About Us
  • Capabilities
  • Products
  • Investors
  • Careers
  • Product Partnering
  • Sustainability
  • CSR
  • Contact Us

© 2026 - Amanta Healthcare, All rights reserved.

Design by Netinc